NAPLEX Flashcards: Prescription Regulations And Safety Warnings

What this deck covers

This deck focuses on Prescription Regulations And Safety Warnings, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.

How to use these flashcards

Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.

Flashcard 1: What is the federal transfer rule for controlled substance prescriptions between pharmacies?

Answer: Schedule III–V: one-time transfer for remaining refills (unless real-time shared DB). Federal rules allow limited transfers of Schedule III-V refills to facilitate patient access without compromising tracking.

Flashcard 2: What is the DEA rule for partial filling a Schedule II prescription for a non-LTCF, non-terminally ill patient?

Answer: Complete within $72$ hours; remainder is void after $72$ hours. The 72-hour rule for partial fills of Schedule II drugs balances drug availability with strict controls to reduce diversion risks.

Flashcard 3: Identify the appropriate action when a patient on isotretinoin is outside the iPLEDGE dispensing window.

Answer: Do not dispense; patient must meet iPLEDGE timing requirements again. iPLEDGE enforces a strict dispensing window to verify pregnancy status and compliance, mitigating teratogenic risks.

Flashcard 4: Identify the required action if a prescription for a controlled substance is missing the prescriber signature.

Answer: Do not dispense; obtain a properly signed prescription per law and policy. A missing signature invalidates the controlled substance prescription under DEA regulations, requiring a valid signed original.

Flashcard 5: Find the federal error: A Schedule III prescription is refilled $6$ times within $6$ months.

Answer: Exceeds limit; maximum is $5$ refills within $6$ months. DEA regulations cap Schedule III refills at 5 within 6 months to limit total dispensings and ensure periodic reassessment.

Flashcard 6: Which auxiliary warning is most appropriate for doxycycline regarding administration with minerals?

Answer: Separate from antacids/iron/calcium by at least $2$ hours when possible. Doxycycline forms chelates with polyvalent cations, reducing absorption and efficacy if not separated appropriately.

Flashcard 7: What is the medication guide requirement for warfarin when dispensing to outpatients?

Answer: Provide the FDA Medication Guide with each dispensing. FDA mandates Medication Guides for high-risk drugs like warfarin to inform patients about bleeding risks and safe use.

Flashcard 8: Which auxiliary warning is most appropriate for metronidazole regarding alcohol use?

Answer: Avoid alcohol during therapy and for at least $3$ days after the last dose. Metronidazole can cause a disulfiram-like reaction with alcohol, necessitating avoidance to prevent severe adverse effects.

Flashcard 9: Identify the correct response to a Schedule II prescription presented with "Refill x3" written on it.

Answer: Do not refill; Schedule II prescriptions have no refills. Federal law strictly prohibits refills for Schedule II drugs to enforce close monitoring and prevent abuse.

Flashcard 10: What is required for a controlled substance prescription to be valid under federal law regarding purpose?

Answer: It must be issued for a legitimate medical purpose in usual professional practice. The Controlled Substances Act mandates that prescriptions serve a valid medical need to prevent misuse and diversion.

Flashcard 11: What is the primary boxed warning associated with clozapine dispensing requirements?

Answer: Severe neutropenia risk; must comply with Clozapine REMS monitoring. Clozapine's boxed warning addresses agranulocytosis risk, requiring REMS to monitor absolute neutrophil counts regularly.

Flashcard 12: Identify the dispensing rule: A patient requests the remainder of a Schedule II partial fill after $96$ hours.

Answer: Remainder is void; cannot dispense after $72$ hours (non-LTCF/non-terminal). The 72-hour limit for completing Schedule II partial fills prevents extended access and potential misuse in standard patients.

Flashcard 13: What is the standard safety warning for opioids when initiating therapy or increasing the dose?

Answer: May cause drowsiness; avoid alcohol and use caution driving or operating machinery. Opioids cause central nervous system depression, increasing risks of impairment that warrant caution with sedatives and activities.

Flashcard 14: What is the DEA rule for partial filling a Schedule II prescription for a terminally ill or LTCF patient?

Answer: May partial fill up to $60$ days from issue date with proper documentation. Extended partial filling for these patients accommodates their ongoing needs while maintaining documentation for oversight.

Flashcard 15: Which auxiliary warning should be used for fluoroquinolones regarding polyvalent cations?

Answer: Do not take with antacids/iron/zinc; separate dosing per product labeling. Fluoroquinolones bind to polyvalent cations, impairing bioavailability and requiring dosing separation to maintain therapeutic levels.

Flashcard 16: Which controlled substance schedules may be transmitted by fax as the original prescription in limited situations?

Answer: Schedule II only for LTCF patients, hospice, or parenteral narcotic for home infusion. Fax transmission is permitted as the original for Schedule II in these cases to expedite care in vulnerable patient populations.

Flashcard 17: What is the key safety warning for acetaminophen-containing products regarding total daily dose?

Answer: Do not exceed $4{,}000$ mg/day from all sources (lower if risk factors). Exceeding the daily acetaminophen limit risks hepatotoxicity, especially in patients with liver impairment or alcohol use.

Flashcard 18: What is the maximum number of refills allowed for Schedule III or IV controlled substance prescriptions?

Answer: Up to $5$ refills within $6$ months of issuance. DEA limits refills for Schedule III and IV drugs to control dispensing while allowing flexibility for chronic conditions.

Flashcard 19: What is the federal maximum quantity permitted on a single Schedule II prescription?

Answer: No federal maximum quantity; limited by legitimate medical purpose and state law. Federal law emphasizes medical legitimacy over quantity caps to accommodate varying patient needs while preventing diversion.

Flashcard 20: What is the maximum time window after issuance to dispense Schedule III or IV refills under federal law?

Answer: All refills must be dispensed within $6$ months. The 6-month limit prevents indefinite refilling of Schedule III and IV prescriptions without prescriber reevaluation.

Flashcard 21: What is the required warning statement for oral isotretinoin prescriptions in the United States?

Answer: iPLEDGE REMS requirements must be met prior to dispensing. iPLEDGE REMS enforces strict protocols to prevent fetal exposure due to isotretinoin's severe teratogenic risks.

Flashcard 22: What is the federal rule for transferring Schedule II prescriptions between pharmacies?

Answer: Transfers are not permitted; a new prescription is required. Prohibiting transfers of Schedule II prescriptions ensures tight control and prevents potential diversion between pharmacies.

Flashcard 23: What is the maximum number of refills allowed for Schedule V controlled substance prescriptions under federal law?

Answer: No federal refill limit; follow prescriber authorization and state law. Schedule V drugs have low abuse potential, so federal law permits unlimited refills based on prescriber judgment and state restrictions.

Flashcard 24: What is the maximum number of refills allowed for a Schedule II controlled substance prescription?

Answer: Zero refills; a new prescription is required each time. Federal regulations prohibit refills for Schedule II substances to minimize abuse potential and ensure ongoing medical necessity.

Flashcard 25: What is the earliest date a Schedule II prescription may be filled if it has a "Do not fill until" date?

Answer: On or after the date specified by the prescriber. This rule allows prescribers to delay dispensing of Schedule II drugs until a specified future date for therapeutic reasons.